Literature DB >> 21436397

Investigations of apoC-III metabolism using stable isotopes: what information can you acquire and how can you interpret your results?

Henry N Ginsberg1, Rajasekhar Ramakrishnan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21436397      PMCID： PMC3090228          DOI： 10.1194/jlr.E015958

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  12 in total

1.  Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.

Authors:  R Batal; M Tremblay; P H Barrett; H Jacques; A Fredenrich; O Mamer; J Davignon; J S Cohn
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

2.  Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.

Authors:  I Shimomura; M Matsuda; R E Hammer; Y Bashmakov; M S Brown; J L Goldstein
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

Review 3.  Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families.

Authors:  P Alaupovic
Journal:  Prog Lipid Res       Date:  1991       Impact factor: 16.195

4.  Apolipoprotein CIII: 42 years old and even more interesting.

Authors:  Henry N Ginsberg; W Virgil Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03       Impact factor: 8.311

5.  Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.

Authors:  Chunyu Zheng; Christina Khoo; Jeremy Furtado; Frank M Sacks
Journal:  Circulation       Date:  2010-04-05       Impact factor: 29.690

6.  Differential metabolism of human VLDL according to content of ApoE and ApoC-III.

Authors:  K Tomiyasu; B W Walsh; K Ikewaki; H Judge; F M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

7.  Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.

Authors:  Dick C Chan; Minh N Nguyen; Gerald F Watts; P Hugh R Barrett
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

Review 8.  Apolipoprotein CIII links dyslipidemia with atherosclerosis.

Authors:  Akio Kawakami; Masayuki Yoshida
Journal:  J Atheroscler Thromb       Date:  2009-03-05       Impact factor: 4.928

9.  Kinetic studies of the metabolism of rapidly exchangeable apolipoproteins may leave investigators and readers with exchangeable results.

Authors:  Henry N Ginsberg; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10       Impact factor: 8.311

10.  Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.

Authors:  Carlos O Mendivil; Chunyu Zheng; Jeremy Furtado; Julian Lel; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311
View more
  1 in total

1.  A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.

Authors:  Sumeet A Khetarpal; Xuemei Zeng; John S Millar; Cecilia Vitali; Amritha Varshini Hanasoge Somasundara; Paolo Zanoni; James A Landro; Nicole Barucci; William J Zavadoski; Zhiyuan Sun; Hans de Haard; Ildikó V Toth; Gina M Peloso; Pradeep Natarajan; Marina Cuchel; Sissel Lund-Katz; Michael C Phillips; Alan R Tall; Sekar Kathiresan; Paul DaSilva-Jardine; Nathan A Yates; Daniel J Rader
Journal:  Nat Med       Date:  2017-08-21       Impact factor: 53.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.